Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation...
Stay updated with breaking news from Leone Patterson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation...
DocuSign Envelope ID: 6C6CA0B7-8C73-439A-9C0D-FB4F60A7ED94 Company No. 3252665 Oxford Biomedica plc (the "Company") Minutes of the Annual Gen...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that it will present new preclinical data at the virtual 28th Annual C...
Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today
Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation Equity Performance: from Sonic Fund letter to Adverum Equity Performance: from Sonic Fund letter to Adverum Image 1: from Sonic Fund letter to Adverum Image 1: from Sonic Fund letter to Adverum Image 2: from Sonic Fund letter to Adverum Image 2: from Sonic Fund letter to Adverum Image 3: from Sonic Fund letter to Adverum Image 3: from Sonic Fund letter to Adverum Image 4: from Sonic Fund letter to Adverum Image 4: from Sonic Fund letter to Adverum Image 5: from Sonic Fund letter to Ad...